Dose-response of arginine-vasopressin (AVP) on blood pressure (MAP), renal macro and micro cortical and medullary flowsin anesthetized rabbits
© The Author(s) 2001
Received: 15 January 2001
Published: 2 March 2001
AVP is a vasopressor used in various clinical vasoplegic situations. Little is known about AVP effect on intact animal for MAP and renal circulation. Anesthetized (pentobarbital) ventilated New Zealand rabbits (2.5–3.3 kg) were studied.
MAP, systolic (SVRen) and diastolic (DVRen) renal blood flow velocities (20 MHz pulsed Doppler); laser Doppler cortical Flcort and medullary Fl med flows.
78.5 ± 14.5
51.6 ± 16.8
20.4 ± 11.8
37.3 ± 6.0
16.8 ± 4.7
Incremental boluses of AVP (1, 2.5, 5, 10, 25, 50, 100, 250, 500 and 1000 ng, 1 ng = 0.4 mU) were i.v. injected. Recording maximal effect, data were expressed in absolute difference from baseline (Δ related to AVP dose).
Two linear curves for MAP, SVRen variations were observed (Fig. 1) with two different slopes (slope1 [doses from 1 to 25 ng AVP] = 0.17 & –0.12 and slope 2 [doses from 50 to 1000 ng AVP] = 0.01 & –0.02 respectively). EC50 (AVP dose inducing half of the response) was calculated from both curves: EC1MAP = 9 ng; EC2MAP = 662 ng; EC1SVRen. = 13 ng; EC2SVRen = 349 ng. The shift from curve 1 to curve 2 occurred at 40 ng for MAP and 68 ng for SVRen of AVP. For DVRen, Flcort, Flmed no linear relation was observed at low AVP doses. For higher AVP doses, similar negative slopes have been calculated: DVRen –0.01; Flcort –0.01; Flmed –0.003.
MAP and SVRen react strongly to low AVP doses whereas DVRen Flcort Flmed did not. At higher dose, Flmed is better preserved than DVRen and Flcor.